Compare Packaging Corporation of America (PKG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Packaging Corporation of America vs State Street SPDR S&P Biotech ETF — how do they compare? Packaging Corporation of America trades at $230.97 (market cap $20.49B), while State Street SPDR S&P Biotech ETF trades at $153.81 (market cap $10.11B). The key difference: Packaging Corporation of America is far larger — about 2× State Street SPDR S&P Biotech ETF's market cap, and Packaging Corporation of America pays a 2.61% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 45 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| PKG | XBI | |
|---|---|---|
Market Cap | $20.49B | $10.11B |
Volume | 493,499 | 12,903,266 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $257.43 | $169.55 |
52-Week Low | $191.68 | $104.99 |
Typical Hold Time | 45 Days | 38 Days |
Enterprise Value | $24.30B | — |
Dividend Yield | 2.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $230.04, up 1.23% on the day, amid a bearish technical signal but with mixed fundamental performance. The stock shows a P/E of 29.86 and net income margin of 7.26%, with Q2 2026 earnings beating estimates. Recent news highlights institutional investments and a scheduled Q3 earnings call, while cash flow trends indicate increased capital expenditures.
PKG presents a cautious outlook with analyst consensus leaning Hold (57.69%) and a price target of $272.43 suggesting upside potential. Key risks include cost pressures and negative net cash flow, but strong corrugated demand and dividend payments offer stability. The stock's performance hinges on Q3 earnings results and margin management amid inflationary headwinds.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
